Abstract:Background Chromoblastomycosis (CMB) is a chronic granulomatous fungal infection that affect the skin and subcutaneous tissues. It is clinically problematic due to limited treatment options, low cure rates, and high rates of relapse. This underscores the necessity for innovative treatment approaches. In this study, potassium iodide (KI) combined with Methylene Blue (MB) mediated antimicrobial photodynamic therapy (PDT) were assessed in the treatment of Fonsecaea monophora (F. monophora) both in vitro and in vivo . And the underlying mechanism that contributes to the efficacy of this treatment approach was investigated. Methods In vitro experiments were conducted using different combinations and concentrations of MB, KI, and 660 nm light (60 mW/cm 2 ) to inhibit F. monophora . The study was carried out using colony-forming unit (CFU) counts and scanning electron microscopy (SEM). The production of singlet oxygen ( 1 O 2 ), free iodine (I 2 ), hydrogen peroxide (H 2 O 2 ), and superoxide anion during the KI combined MB-mediated antimicrobial PDT process was also detected. In vivo experiments were developed using a Balb/c mouse paw infection model with F. monophora and treated with PBS, 10mM KI, 2 mM MB +100 J/cm2 and 10mM KI+2mM MB +100 J/cm2 respectively. Inflammatory swelling, fungal load and histopathological analyses of the mouse footpads were assessed. Results KI enhanced the killing effect of MB-mediated antimicrobial PDT on the conidial spores of F. monophora at the cell and infected animal model level. During the process, the main antimicrobial agents in KI combined with MB- mediated antimicrobial PDT could produce stronger toxic active species including free I 2 and H 2 O 2. Conclusion KI combined with MB-mediated antimicrobial PDT could be an effective adjunct therapy for treating CBM.

An overview on the treatment of chromoblastomycosis

Successful management of chromoblastomycosis utilizing conventional antifungal agents and imiquimod therapy

Chromoblastomycosis: still a therapeutic challenge

Neutrophil extracellular traps (NETs) and Th-2 dominant immune responses in chronic granulomatous chromobalstomycosis

The Species Distribution of Candidemia and the Advances on Diagnosis and Treatment

Progress in molecular diagnosis and treatment of chronic mucocutaneous candidiasis

Successful treatment of Candida tropicalis osteomyelitis with Micafungin in a leukemia patient

Chromoblastomycosis: A Single Centre Clinical Laboratory Experience of Seven Years (2016-2022) and Literature Review From Pakistan

Successful Treatment of Chromoblastomycosis of 10-Year Duration Due to Fonsecaea Nubica

A Refractory Case of Chromoblastomycosis Due to Fonsecaea Monophora with Improvement by Photodynamic Therapy.

Chromoblastomycosis: A Potential Mimic of Squamous Cell Carcinoma in Transplant Recipients

In vitro susceptibility of chromoblastomycosis agents to five antifungal drugs and to the combination of terbinafine and amphotericin B

Successfully treatment of chromoblastomycosis with itraconazole and terbinafine association:a case report

Potassium Iodide Enhances the Killing Effect of Methylene Blue Mediated Photodynamic Therapy Against F. monophora

An Overview of Myeloid Blast-Phase Chronic Myeloid Leukemia

Clinical treatment of cryptococcal meningitis: an evidence-based review on the emerging clinical data

A global chromoblastomycosis strategy and development of the global chromoblastomycosis working group

Successful treatment for chromoblastomycosis caused by Fonsecaea monophora: a report of three cases in Guangdong, China.

Successful treatment for chromoblastomycosis caused by <i>Fonsecaea monophora</i>: a report of three cases in Guangdong, China

Chinese Chronic Mucocutaneous Candidiasis: A Case Report Series

Mucormycosis after CD19 chimeric antigen receptor T-cell therapy: results of a US Food and Drug Administration adverse events reporting system analysis and a review of the literature